City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation

Border Border
The following is a list of available studies directed by  Amrita Y. Krishnan, MD  
Search results:  2  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-2 Trials Jump to page:

COH Protocol Number: 08102 Number: NCT00628498

Principal Investigator: Amrita Krishnan, MD
Sponsor: Industrial

Title:  Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study(Under CFR 312.34)

COH Protocol Number: 07076 Number: NCT00695409

Principal Investigator: Amrita Krishnan, MD
Sponsor: NCI Approved External Peer Review

Title:  A Phase II Study of Yttrium-90-Labeled Anti-CD20 Monoclonal Antibody in Combination with High-Dose Beam (BCNU, Etoposide, Cytarabine and Melphalan) Followed by Autologous Stem Cell Transplantation for Patients with Poor Risk/Relapsed B-Cell Lymphoma

Results per page: 25 50 100 All 1-2 Trials Jump to page:

NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.